Texas could be setting a new standard for access to ivermectin, a drug traditionally used as an anti-parasitic treatment for livestock, which also gained unproven traction as a COVID-19 remedy. As reported by Click2Houston, a bill underway in the special legislative session, House Bill 25, is advocating for Texans to obtain ivermectin over the counter, without a prescription. Filed by State Rep. Joanne Shofner, R-Nacogdoches, the bill echoes the sentiment that ease of access should prevail in rural areas where medical facilities are sparse.
In defense of the bill, Shofner remarked, “If it didn’t work, no one would be interested in it,” and emphasized stories of rapid recovery post-ivermectin use. She suggested the drug's availability could effectively bridge the distance to healthcare professionals for her constituents, where simply visiting a doctor could take over an hour's drive - a feat in comparison to the short walk to a local Walgreens. These views were compounded by the backing of Gov. Greg Abbott, who has added ivermectin access to his list of priorities after receiving support from Texans for Vaccine Choice, which rallied with 7,000 signatures, as noted by The Texas Tribune.
The push for prescription-free ivermectin resonates with advocates of medical freedom, believing in the right to choose alternative medications to conventional vaccines, Texas included among 15 states considering similar legislation. The Food and Drug Administration, however, has not sanctioned ivermectin for COVID-19, a stance at odds with the bill's proponents. As shared by Click2Houston, the drug gained popularity through social media in the pre-vaccine era of the pandemic, despite official warnings and an uptick in reported side effects.
Opposition voices worry that availability without prescription neglects the risks associated with uninformed self-medication. State Rep. John Bucy III, D-Austin, who serves on the House Public Health Committee, has voiced his concerns, arguing, "You’re taking the doctor out of the equation," and that the bill could lead to increased misuse, especially to the vulnerable. According to The Texas Tribune, Bucy plans to vote against HB 25, seeking better safeguards for public health while insisting on clearer labeling to protect children, although the bill overlooks these considerations.
Under the proposed legislation, a conversation with a pharmacist detailing potential side effects, which can include nausea and dizziness, remains necessary prior to dispensing the drug. Testimonies from the public illustrate a divide, with supporters lauding ivermectin's safety and efficacy, while critiques express concern over the drug's uncertain role in treating COVID-19 and the potential for political motivations shaping health policy. The Texas Medical Association, against the bill, fears the deterioration of the physician-patient relationship crucial for safe prescribing practices, while Texas Board of Pharmacy, a key stakeholder, has yet to comment publicly on the matter.
With Texans for Vaccine Choice declaring that HB 25 would let Texans "take their health into their own hands," this legislative move reflects a broader discussion on who should be the arbitrator of health decisions - professionals or patients, as mentioned by The Texas Tribune.
